Merel Ritskes-Hoitinga (SYRCLE, Department for Health Evidence) has been appointed honorary Skou Professor at the Department of Clinical Medicine, at Aarhus University, Denmark.
The official inauguration of 47 Honorary Skou Professors was held 8 October 2019 in Aarhus https://health.au.dk/en/research/honorary-skou-professors/.
The aim is to introduce new perspectives to teaching, strengthen relations with leading research units abroad and establish joint research projects and funding applications. The Skou Professors will participate in the academic work of the individual departments, e.g. as guest lecturers and co-supervisors on PhD projects, in the form of research partnerships and joint funding applications or as guest lecturers at conferences. In order to connect the Skou professors to their respective departments in the best way, each of them has been affiliated to a ‘champion’. For Prof. Merel Ritskes-Hoitinga this is Prof. Dr. Gregers Wegener at the Department of Clinical Medicine at the Translational Neuropsychiatry Unit.Together with Dr. Birgitte Kousholt, Prof. Wegener has founded AUGUST https://august.au.dk/. Merel Ritskes-Hoitinga, Gregers Wegener and Birgitte Kousholt have already been working closely together for a number of years in setting up teaching and research in the field of preclinical systematic reviews, and the official appointment as honorary Skou professor will stimulate and broaden this work further. Merel Ritskes-Hoitinga held her inaugural lecture on 9 October 2019, with the title “The benefits of preclinical systematic reviews”.
Merel Ritskes - Hoitinga is member of theme Reconstructive and regenerative medicine.
Related news items
Ritalin enhances your ability to do tasks by making you more motivated26 March 2020
A new study uncovers how stimulants like Ritalin work in the brain, and it challenges some misconceptions for its recreative use. The collaboration between Radboudumc and Brown University (USA) was published in the journal Science.read more
Dealing with COVID-19 in low- and middle-income countries26 March 2020
RIHS researcher Joost Hopman believes that low-and middle-income countries should intensify their preparedness for a possible COVID-19 outbreak. This was the core message of an opinion article that he wrote at the request of the medical journal JAMA.read more
Physiotherapy is important to the recovery of patients with the coronavirus26 March 2020
Patients who have been infected with the coronavirus and admitted to the hospital for this reason should receive physiotherapy as soon as their condition allows. This is the view expressed by physiotherapists and researchers from the Radboudumc in a set of joint treatment recommendations.read more
Healthcare utilization and regional variation of end-of-life hospital care in Dutch cancer patients26 March 2020
In International Journal of Quality Health Care RIHS researcher Femke Atsma showed high healthcare utilization and medical variation in End of Life care in Cancer patients, which was not associated with GP care or long term care.read more
Study into better protection for healthcare workers against coronavirus infection19 March 2020
Radboudumc and UMC Utrecht will investigate whether health care workers are better protected against the coronavirus after a vaccination against tuberculosis (BCG vaccine). This vaccine does not directly protect against the coronavirus, but provides a boost to the immune system.read more
Differences in the placental disposition of TNF inhibitors uncovered19 March 2020
In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept.read more